-
DiscoveryDNA-encoded molecules provide a new edge in cancer drug hunts
Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.
Discovery -
Access to HealthcareMalaria is still disrupting lives, despite progress
The disease hobbles families and economies.
Access to Healthcare -
DiscoveryBuilding “boot camps” for immune cells near tumors
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
Discovery -
Access to HealthcarePositive gains are needed to accelerate change for women with lung disease
COPD receives low attention as a women’s health issue. It’s time to change that.
Access to Healthcare -
DiscoveryTaking on obesity
Novartis is developing an experimental drug for weight loss.
Discovery -
DiscoveryPotential weight loss treatment takes shape with help from patients
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
Discovery -
DiscoveryCompound designed to fight Alzheimer’s disease shows promise in the lab
The molecule restores the activity of neurons and neural circuits in a model of the disease.
Discovery -
Access to HealthcarePartnering for improved cancer care around the globe
Novartis works tirelessly with third-party organizations to improve access to cancer care.
Access to Healthcare -
Access to HealthcareLiving with breast cancer in Uganda
Suzan Akello describes what life has been like since her cancer diagnosis.
Access to Healthcare -
DiscoveryTracking patients’ progress with radio signals and machine learning
Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
Discovery -
DiscoveryOrganic dealmaker for drug discovery
New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
Discovery -
DiscoveryOpen science demystified
Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.
Discovery